MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CRBU has $148,998K in assets. $46,980K in debts. $12,057K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
622.08%
Quick Ratio
622.08%
Cash Ratio
61.29%
Debt to Asset Ratio
31.53%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, short-ter...
    • Operating lease, right of use as...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
12,057 12,360 11,144 25,201
Marketable securities, short-term
105,569 126,980 136,115 158,747
Accounts receivable
227 69 242 71
Contract assets
691 1,006 860 753
Other receivables
1,445 1,904 1,828 1,956
Prepaid expenses and other current assets
2,392 2,913 5,317 5,778
Total current assets
122,381 145,232 155,506 192,506
Equity method investments
-0 143 132
Marketable securities, long-term
1,001 3,505 11,953 0
Property and equipment, net
6,123 6,760 7,598 8,179
Operating lease, right of use assets
17,356 17,670 16,004 16,461
Other assets
2,137 2,200 3,780 3,625
Total assets
148,998 175,367 194,984 220,903
Accounts payable
3,503 5,783 3,804 3,243
Accrued expenses and other current liabilities
13,889 16,535 19,350 20,528
Operating lease liabilities, current
1,287 1,201 2,687 2,287
Deferred revenue
994 1,895 2,217 2,829
Deferred tax liabilities
-0 548 548
Total current liabilities
19,673 25,414 28,058 28,887
Deferred revenue, net of current portion
1,648 1,752 1,756 1,772
Mskcc success payments liability
-0 0 0
Operating lease liabilities, non-current
25,659 26,026 22,777 23,564
Total liabilities
46,980 53,192 53,139 54,771
Common stock, par value 0.0001 per share, 300,000,000 shares authorized as of march31, 2026, and december31, 2025 96,951,234 and 95,143,690 shares issued and outstanding as of march31, 2026, and december31, 2025, respectively
10 9 9 9
Additional paid-in-capital
723,631 718,578 711,770 708,562
Accumulated other comprehensive (loss) income
-23 103 93 40
Accumulated deficit
-621,600 -596,515 -570,027 -542,479
Total stockholders equity
102,018 122,175 141,845 166,132
Total liabilities and stockholders equity
148,998 175,367 194,984 220,903
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities,short-term$105,569K Cash and cashequivalents$12,057K Prepaid expenses andother current assets$2,392K Other receivables$1,445K Contract assets$691K Accounts receivable$227K Total current assets$122,381K Operating lease, right ofuse assets$17,356K Property and equipment,net$6,123K Other assets$2,137K Marketable securities,long-term$1,001K Total assets$148,998K Total liabilities andstockholders equity$148,998K Total stockholdersequity$102,018K Total liabilities$46,980K Accumulated deficit-$621,600K Accumulated othercomprehensive (loss) income-$23K Additionalpaid-in-capital$723,631K Operating leaseliabilities, non-current$25,659K Total currentliabilities$19,673K Deferred revenue, net ofcurrent portion$1,648K Common stock, par value0.0001 per share,...$10K Accrued expenses andother current...$13,889K Accounts payable$3,503K Operating leaseliabilities, current$1,287K Deferred revenue$994K

Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences, Inc. (CRBU)